RecruitingNot applicableNCT06305234

A Long Term, Post-marketing Study of Immune Response in Patients Receiving Palynziq Treatment for PKU (PALisade)

Studying Phenylketonuria

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
BioMarin Pharmaceutical
Principal Investigator
Medical Director, MD, M.D
BioMarin Pharmaceutical
Intervention
Pegvaliase(drug)
Enrollment
200 enrolled
Eligibility
All sexes
Timeline
20242033

Study locations (6)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06305234 on ClinicalTrials.gov

Other trials for Phenylketonuria

Additional recruiting or active studies for the same condition.

See all trials for Phenylketonuria

← Back to all trials